NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM
申请人:Institut National de la Recherche Scientifique
公开号:EP2729184A1
公开(公告)日:2014-05-14
[EN] TETRACYCLIC INHIBITORS OF JANUS KINASES<br/>[FR] INHIBITEURS TETRACYCLIQUES DE JANUS KINASES
申请人:INCYTE CORP
公开号:WO2007038215A1
公开(公告)日:2007-04-05
[EN] The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. [FR] Cette invention concerne des composés qui modulent l'activité des Janus kinases et qui sont utilisés dans le traitement de maladies associées à l'activité des Janus kinases parmi lesquelles, par exemple, des maladies immunitaires, des affections cutanées, des syndromes myéloprolifératifs, le cancer et d'autres maladies.
[EN] NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM<br/>[FR] NOUVEAUX AGONISTES ET ANTAGONISTES DU SYSTÈME UROTENSINERGIQUE
申请人:INST NAT RECH SCIENT
公开号:WO2012149644A1
公开(公告)日:2012-11-08
Novel urotensin II receptor (UT) agonists and antagonists are described herein. More specifically, novel derivatives of urotensin ll-related peptide (URP) are described herein.
Synthesis of methyl (±)-7-oxo-8-methyl-podocarp-8-en-16-oate